Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer

NCT05999812 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: all trans Retinoic Acid
DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]